Media monitor
"There are people whose window of opportunity is very brief to get these therapies. As far as I'm concerned, he's condemning them."
—Irving Weissman, MD, the Virginia and DK Ludwig Professor for Clinical Investigation and director of the Stanford Institute for Stem Cell Biology and Regenerative Medicine, on Sen. Sam Brownback's (R-Kan.) bill that proposes making it a crime to place human brain cells in animals. Business Week, Jan. 16 http://www.businessweek.com/magazine/content/06_03/b3967109.htm
"This is a story that needs to get out there."
—James Lock, MD, PhD, associate professor of psychiatry and behavioral sciences at Lucile Packard Children's Hospital, on the lack of resources in the Bay Area for people suffering from eating disorders. San Francisco Chronicle, Jan. 6 http://sfgate.com/cgi-bin/article.cgi?f=/c/a/2006/01/06/PNGQEGF2TO1.DTL
"I'd say three to five years, if it's on a fast track."
—David Lewis, MD, professor of pediatrics, discussing the news that Stanford and Juvaris BioTherapeutics have been awarded a two-year federal grant totaling nearly $1 million to begin developing a vaccine to counter a possible outbreak of bird flu. San Jose Mercury News, Jan. 9 http://www.mercurynews.com/mld/mercurynews/13584152.htm (registration required)
"There are many little tricks. . . .It's almost like an art."
—Nelson Teng, MD, associate professor of obstetrics and gynecology and director of gynecological oncology, on why abdominal chemotherapy, which the National Cancer Institute recently recommended be adopted as a standard treatment for ovarian cancer, has not been a widely used therapy. New York Times, Jan. 17. http://www.nytimes.com/2006/01/17/health/17ovar.html?pagewanted=1 (registration required)